THE UNIV OF TENNESSEE RESEARCH FOUNDATION has a total of 14 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets medical technology, pharmaceuticals and measurement are GLOBAL BIO THERAPEUTICS INC, VASOGEN IRELAND LTD and GLOBAL BIO THERAPEUTICS USA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 4 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Lindner Erno | 8 |
#2 | Guo Jidong | 8 |
#3 | Chaum Edward | 8 |
#4 | Postlethwaite Arnold E | 2 |
#5 | Krishnamurthy Mathangi | 1 |
#6 | Smith Jena Steinle | 1 |
#7 | Chen Jiyun | 1 |
#8 | Tigyi Gabor | 1 |
#9 | Gu Weikuan | 1 |
#10 | Hwang Dong Jin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018222820A1 | Method and device for detection of bioavailable drug concentration in a fluid sample | |
US2018271413A1 | Method and device for detection of bioavailable drug concentration in a fluid sample | |
US2017370880A1 | Method and device for detection of bioavailable drug concentration in a fluid sample | |
US2017143652A1 | Method for regulating retinal endothelial cell viability | |
US2015119848A1 | Method and device for detection of bioavailable drug concentration | |
AU2003216153A1 | Multi-substitued selective androgen receptor modulators and methods of use thereof |